- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Optomed PLC (OPTOMED)
Track today's live Optomed (OPTOMED) share price, performance and key data on this page with our current Helsinki:OPTOMED stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Optomed share price on the Helsinki exchange. Use the dropdown to switch exchange for the OPTOMED share price, head to our technical summary section, which provides analysis on Optomed share price buy/sell indicators using real-time data (or discuss the Optomed (OPTOMED) stock price today with other investors in the Optomed HE share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current HE:OPTOMED share price (ISIN: FI4000410881) to enhance your trading decisions with our free investment tools and resources.
What Is the Optomed PLC Share Price Today?
The Optomed share price today is 1.76.
What Is the Stock Symbol for Optomed PLC
The stock symbol (or 'ticker') for Optomed PLC is "OPTOMED."
What Stock Exchange Does Optomed PLC Trade On?
Optomed PLC is listed and trades on the Helsinki stock exchange.
Is Optomed PLC a Good Stock to Buy?
Determining whether Optomed (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current HE:OPTOMED share price (ISIN: FI4000410881) to enhance your trading decisions with our free investment tools and resources.
What Is the Optomed PLC Share Price Today?
The Optomed share price today is 1.76.
What Is the Stock Symbol for Optomed PLC
The stock symbol (or 'ticker') for Optomed PLC is "OPTOMED."
What Stock Exchange Does Optomed PLC Trade On?
Optomed PLC is listed and trades on the Helsinki stock exchange.
Is Optomed PLC a Good Stock to Buy?
Determining whether Optomed (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
1.76
-0.03(-1.78%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.76
1.84
52 wk Range
1.33
4.75
OPTOMED is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.761.84
52 wk Range
1.334.75
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
OPTOMED Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PricePrice Target
2.40
Upside
+36.36%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
Analyst Ratings
1 Buy
1 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 2.40
(+36.36% Upside)
Earnings
Latest Release
03/06/2026
EPS / Forecast
-0.05 / -0.07
Revenue / Forecast
3.38M / 4.33M
Compare OPTOMED to Peers and Sector
Metrics to compare | OPTOMED | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipOPTOMEDPeersSector | |
|---|---|---|---|---|
P/E Ratio | −6.1x | 7.9x | −0.4x | |
PEG Ratio | −6.39 | 0.14 | 0.00 | |
Price/Book | 1.7x | 2.6x | 2.6x | |
Price / LTM Sales | 2.3x | 0.7x | 3.0x | |
Upside (Analyst Target) | 11.7% | 4.9% | 55.7% | |
Fair Value Upside | Unlock | 17.0% | 8.1% | Unlock |
Optomed Oyj, together with its subsidiaries, manufactures and sells handheld fundus cameras in Finland, rest of Europe, and internationally. The company operates in two segments, Devices and Software. It develops, manufactures, and sells fundus cameras for ophthalmologists, pediatricians, endocrinologists, neurologists, and primary health care professionals; and provides professional IT consulting services for government institutions. The company also provides camera products under the Optomed Smartscope Pro, Optomed Aurora, Optomed Aurora AEYE, Optomed Polaris, and Optomed Lumo brand names, as well as OEM cameras under the Volk Optical, Carl Zeiss Meditec, and Topcon brands. The company provides Avenue AI, an AI streamlines eye specialists’ work and minimises screening costs; Avenue Eye Screen, a workflow management software for screening and monitoring of eye diseases; Avenue Flow, an eyecare management software; and Avenue Telemedicine, a remote analysis solution. In addition, it offers Cancer Screen, a screening process management software; Optomed Radiology Information System, a software solution for healthcare imaging units; Sectra PACS, a modular system for healthcare providers; Optomed Service Portal, a support function for healthcare units; Cephalometry, a powerful, flexible, and easy-to-use Windows software for orthodontics, oral and maxillofacial surgery; and Pathology PACS, which allows digital pathology images to be reviewed and shared. Optomed Oyj was incorporated in 2004 and is headquartered in Oulu, Finland.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Optomed (Helsinki: OPTOMED) Share Price Today?
The Optomed stock price today is 1.76 EUR.
What Stock Exchange Does Optomed (OPTOMED) Trade On?
Optomed is listed and trades on the Helsinki Stock Exchange.
What Is the Ticker (Stock Symbol) for Optomed?
The stock symbol (also called a 'ticker') for Optomed is "OPTOMED."
What Is the Current Optomed Market Capitalisation?
As of today, Optomed (Helsinki: OPTOMED) market cap is 38.45M EUR.
What Is Optomed's (OPTOMED) Earnings Per Share (TTM)?
The Optomed EPS is currently -0.31 (Trailing Twelve Months).
When Is the Next Optomed Earnings Date?
Optomed's next earnings report will be released on 02/09/2026.
Is OPTOMED a Buy or Sell From a Technical Analyst Perspective?
Based on today's Optomed moving averages and other technical indicators, the daily buy/sell signal for OPTOMED stock is Buy.
How Many Times Has Optomed Stock Split?
Optomed has split 0 times. (See the OPTOMED stock split history page for full effective split date and price information.)
How Many Employees Does Optomed Have?
Optomed has 110 employees, based on their latest Companies House report.
What is the current trading status of Optomed (Helsinki: OPTOMED)?
As of 25/06/2026, Optomed (OPTOMED) is trading at a share price of 1.76 EUR, with a previous close of 1.79 EUR. The stock has fluctuated within a day range of 1.76 EUR to 1.84 EUR, while its 52-week range spans from 1.33 EUR to 4.75 EUR.
What Is Optomed (OPTOMED) Price Target According to Analysts?
The average 12-month price target for Optomed is 2.40 EUR, with a high estimate of 3.5 EUR and a low estimate of 1.7 EUR. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +36.36% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.